Latest Science News
WHO: Hantavirus Outbreak Risk Remains 'Absolutely Low' Despite Cruise Ship Cases
The World Health Organization has confirmed five hantavirus cases from the MV Hondius cruise ship, with three fatalities reported . Despite the outbreak, WHO states the risk of a global pandemic remains "absolutely low" but warns that more cases could emerge and precautions must be taken to limit spread
. Health officials are actively tracing passengers who departed before the outbreak was detected
.
Singapore Residents Test Negative for Hantavirus After Cruise Ship Exposure
Two Singapore residents who were monitored for possible hantavirus symptoms after exposure on the cruise ship have tested negative for the virus . The individuals will remain quarantined for 30 days from their last exposure date and will be tested again before release
.
Spain Detects Suspected Hantavirus Case Linked to Cruise Ship
Spain has identified a suspected hantavirus case as authorities prepare to receive remaining passengers from the MV Hondius cruise ship at the Canary Islands this weekend . A third British national is also suspected of carrying the virus, while a KLM flight attendant tested negative after potential exposure to an infected passenger
.
Malaria Vaccine Prevents One in Eight Child Deaths in African Rollout
A significant public health breakthrough shows that the malaria vaccine has averted 1 in 8 child deaths across three African countries during its first rollout . This represents a major advancement in combating malaria mortality in high-risk regions.
Specialized RNA Molecules Show Promise Against ALS Neurodegeneration
New research into specialized RNA molecules offers potential therapeutic approaches to counter amyotrophic lateral sclerosis (ALS) neurodegeneration . This development represents progress in treating one of the most challenging neurodegenerative diseases.
'Forever Chemicals' Found in 98.5% of People Tested Worldwide
A comprehensive study reveals that man-made PFAS (per- and polyfluoroalkyl substances), known as 'forever chemicals,' have been detected in 98.5% of people tested . These persistent chemicals accumulate in the environment and human bodies, raising significant public health concerns.
Antarctica Facing Triple Climate Crisis with Record Sea Ice Loss
A new study reveals that Antarctica is experiencing a triple-whammy of climate chaos, with sea ice melting to record lows, defying decades of resistance to global warming trends . The findings indicate accelerating climate change impacts on Earth's polar regions.
Urine Test Outperforms MRI for Monitoring Low-Risk Prostate Cancer
Researchers have demonstrated that a urine test is more effective than MRI for monitoring low-risk prostate cancer in new clinical studies . This advancement could improve patient outcomes by providing a less invasive and more accurate monitoring method.
Asteroid Apophis Will Pass Earth in 2029 Under ESA and JAXA Joint Observation
The European Space Agency (ESA) and Japan Aerospace Exploration Agency (JAXA) have signed agreements to collaborate on planetary defense, including a dedicated mission to monitor asteroid Apophis as it skims past Earth in 2029 . This marks enhanced international cooperation in tracking potentially hazardous near-Earth objects.
Malaysia Plans Cloud Seeding to Combat Drought in Agricultural 'Rice Bowl'
Malaysia is implementing cloud seeding technology to address a severe drought affecting the country's northern rice-growing region, where dry conditions have delayed crop planting and raised food supply concerns . The intervention aims to restore rainfall and support agricultural productivity.
IL-10 Gene Therapy Shows Promise in Boosting Immune Response Against Liver Cancer
Research using IL-10 gene therapy has demonstrated the ability to enhance immune system attacks against liver cancer in laboratory studies . This genetic therapy approach represents a novel direction in cancer treatment research.
FDA Approves New Technology for Breast Cancer Treatment
Regulatory approval has been granted for a new technology designed to treat breast cancer, marking another advancement in cancer care options . The approval represents progress in expanding therapeutic tools for breast cancer patients.